Rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolaemia: Economic analysis of the POLARIS study

被引：1
|
作者：
Miller, PSJ
Leiter, LA
Davies, A
Sosef, F
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Univ Toronto, Dept Med & Nutrit Sci, Toronto, ON, Canada
[3] Medtap Inc, London, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2005年 / 6卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(05)80451-9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease
    Conard, Scott E.
    Bays, Harold E.
    Leiter, Lawrence A.
    Bird, Steven R.
    Rubino, Joseph
    Lowe, Robert S.
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (11): : 1489 - 1494
  • [22] INTENSIVE DOSE OF ROSUVASTATIN (40 MG/DAY), INITIATED EARLY AND CONTINUED FOR 12 WEEKS, IN VERY HIGH-RISK OR HIGH-RISK INDIAN PATIENTS
    Shah, C.
    ATHEROSCLEROSIS, 2015, 241 (01) : E201 - E201
  • [23] Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease
    Lopez-Cuenca, Angel
    Marin, Francisco
    Roldan, Vanessa
    Climent, Vicente E.
    Valdes, Mariano
    Lip, Gregory Y. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 139 (01) : 95 - 97
  • [24] Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction
    Tuncez, Abdullah
    Altunkeser, Bulent Behlul
    Ozturk, Bahadir
    Ates, Muhammed Salih
    Tezcan, Huseyin
    Aydogan, Canan
    Kirik, Emre Can
    Yalcin, Ulvi
    Aygul, Nazif
    Demir, Kenan
    Akyurek, Fikret
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2019, 22 (05): : 240 - 249
  • [25] Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
    Viigimaa, Margus
    Vaverkova, Helena
    Farnier, Michel
    Averna, Maurizio
    Missault, Luc
    Hanson, Mary E.
    Dong, Qian
    Shah, Arvind
    Brudi, Philippe
    LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [26] Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
    Margus Viigimaa
    Helena Vaverkova
    Michel Farnier
    Maurizio Averna
    Luc Missault
    Mary E Hanson
    Qian Dong
    Arvind Shah
    Philippe Brudi
    Lipids in Health and Disease, 9
  • [27] Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack
    Palacio, Enrique
    Viadero-Cervera, Raquel
    Revilla, Marian
    Larrosa-Campo, Davinia
    Acha-Salazar, Olga
    Novo-Robledo, Francisco
    Oterino, Agustin
    REVISTA DE NEUROLOGIA, 2016, 62 (05) : 203 - 210
  • [28] Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study
    Ballantyne, Christie M.
    Hoogeveen, Ron C.
    Raya, Joe L.
    Cain, Valerie A.
    Palmer, Mike K.
    Karlson, Bjorn W.
    ATHEROSCLEROSIS, 2014, 232 (01) : 86 - 93
  • [29] Comparison of Effects of Rosuvastatin (10 mg) Versus Atorvastatin (40 mg) on Rho Kinase Activity in Caucasian Men With a Previous Atherosclerotic Event
    Rawlings, Ron
    Nohria, Anju
    Liu, Ping-Yen
    Donnelly, Jason
    Creager, Mark A.
    Ganz, Peter
    Selwyn, Andrew
    Liao, James K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (04): : 437 - 441
  • [30] A Comparison of Switching to Ezetimibe/Simvastatin (10 mg/20 mg) versus Doubling the Statin Dose to Simvastatin 40 mg or Atorvastatin 20 mg or Switching to Rosuvastatin 10 mg in Patients with Cardiovascular Disease and Diabetes Mellitus
    Rosen, Jeffrey B.
    Jimenez, Jose G.
    Pirags, Valdis
    Vides, Hella
    Hanson, Mary E.
    Massaad, Rachid
    McPeters, Gail
    Triscari, Joseph
    Brudi, Philippe
    CIRCULATION, 2011, 124 (21)
12345